186 related articles for article (PubMed ID: 27895979)
1. Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism.
Alhallak K; Rebello LG; Muldoon TJ; Quinn KP; Rajaram N
Biomed Opt Express; 2016 Nov; 7(11):4364-4374. PubMed ID: 27895979
[TBL] [Abstract][Full Text] [Related]
2. Potential Biomarker for Triple-Negative Breast Cancer Invasiveness by Optical Redox Imaging.
Feng M; Xu HN; Jiang J; Li LZ
Adv Exp Med Biol; 2021; 1269():247-251. PubMed ID: 33966225
[TBL] [Abstract][Full Text] [Related]
3. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
[TBL] [Abstract][Full Text] [Related]
4. Optical Redox Imaging Detects the Effects of DEK Oncogene Knockdown on the Redox State of MDA-MB-231 Breast Cancer Cells.
Wen Y; Xu HN; Privette Vinnedge L; Feng M; Li LZ
Mol Imaging Biol; 2019 Jun; 21(3):410-416. PubMed ID: 30758703
[TBL] [Abstract][Full Text] [Related]
5. Potential Indexing of the Invasiveness of Breast Cancer Cells by Mitochondrial Redox Ratios.
Sun N; Xu HN; Luo Q; Li LZ
Adv Exp Med Biol; 2016; 923():121-127. PubMed ID: 27526133
[TBL] [Abstract][Full Text] [Related]
6. Visualization of Breast Cancer Metabolism Using Multimodal Nonlinear Optical Microscopy of Cellular Lipids and Redox State.
Hou J; Williams J; Botvinick EL; Potma EO; Tromberg BJ
Cancer Res; 2018 May; 78(10):2503-2512. PubMed ID: 29535219
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Optical Redox Imaging of Melanoma Xenografts with Different Metastatic Potentials.
Peng A; Xu HN; Moon L; Zhang P; Li LZ
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730620
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence intensity and lifetime redox ratios detect metabolic perturbations in T cells.
Hu L; Wang N; Cardona E; Walsh AJ
Biomed Opt Express; 2020 Oct; 11(10):5674-5688. PubMed ID: 33149978
[TBL] [Abstract][Full Text] [Related]
9. Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes.
Jiang J; Feng M; Jacob A; Li LZ; Xu HN
Adv Exp Med Biol; 2021; 1269():253-258. PubMed ID: 33966226
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
Manka D; Spicer Z; Millhorn DE
Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging.
Xu HN; Zheng G; Tchou J; Nioka S; Li LZ
Springerplus; 2013 Dec; 2(1):73. PubMed ID: 23543813
[TBL] [Abstract][Full Text] [Related]
12. High-throughput measurements of the optical redox ratio using a commercial microplate reader.
Cannon TM; Shah AT; Walsh AJ; Skala MC
J Biomed Opt; 2015 Jan; 20(1):010503. PubMed ID: 25634108
[TBL] [Abstract][Full Text] [Related]
13. Quantitative redox imaging biomarkers for studying tissue metabolic state and its heterogeneity.
Xu HN; Li LZ
J Innov Opt Health Sci; 2014 Mar; 7(2):. PubMed ID: 31827630
[TBL] [Abstract][Full Text] [Related]
14. Evaluating differences in optical properties of indolent and aggressive murine breast tumors using quantitative diffuse reflectance spectroscopy.
Rodriguez Troncoso J; Marium Mim U; Ivers JD; Paidi SK; Harper MG; Nguyen KG; Ravindranathan S; Rebello L; Lee DE; Zaharoff DA; Barman I; Rajaram N
Biomed Opt Express; 2023 Dec; 14(12):6114-6126. PubMed ID: 38420330
[TBL] [Abstract][Full Text] [Related]
15. MITOCHONDRIAL REDOX IMAGING FOR CANCER DIAGNOSTIC AND THERAPEUTIC STUDIES.
Li LZ; Xu HN; Ranji M; Nioka S; Chance B
J Innov Opt Health Sci; 2009 Oct; 2(4):325-341. PubMed ID: 26015810
[TBL] [Abstract][Full Text] [Related]
16. An engineered niche delineates metastatic potential of breast cancer.
Orbach SM; DeVaull CY; Bealer EJ; Ross BC; Jeruss JS; Shea LD
Bioeng Transl Med; 2024 Jan; 9(1):e10606. PubMed ID: 38193115
[TBL] [Abstract][Full Text] [Related]
17. Optical imaging of metabolism in HER2 overexpressing breast cancer cells.
Walsh A; Cook RS; Rexer B; Arteaga CL; Skala MC
Biomed Opt Express; 2012 Jan; 3(1):75-85. PubMed ID: 22254170
[TBL] [Abstract][Full Text] [Related]
18. Raman spectroscopy reveals phenotype switches in breast cancer metastasis.
Paidi SK; Troncoso JR; Harper MG; Liu Z; Nguyen KG; Ravindranathan S; Rebello L; Lee DE; Ivers JD; Zaharoff DA; Rajaram N; Barman I
Theranostics; 2022; 12(12):5351-5363. PubMed ID: 35910801
[TBL] [Abstract][Full Text] [Related]
19. Mapping metabolic changes by noninvasive, multiparametric, high-resolution imaging using endogenous contrast.
Liu Z; Pouli D; Alonzo CA; Varone A; Karaliota S; Quinn KP; Münger K; Karalis KP; Georgakoudi I
Sci Adv; 2018 Mar; 4(3):eaap9302. PubMed ID: 29536043
[TBL] [Abstract][Full Text] [Related]
20. Development of an Endoscopic Auto-Fluorescent Sensing Device to Aid in the Detection of Breast Cancer and Inform Photodynamic Therapy.
Gaitan B; Inglut C; Kanniyappan U; Xu HN; Conant EF; Frankle L; Li LZ; Chen Y; Huang HC
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
